Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Max Bodach and Foundation for American Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Max Bodach and Foundation for American Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Counterfeit Cloud over U.S.-China Trade w/ Joel Thayer

46:42
 
Share
 

Manage episode 472619620 series 3530279
Content provided by Max Bodach and Foundation for American Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Max Bodach and Foundation for American Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

It’s an understatement that U.S.-China relations have been tense in recent years. Policymakers and industry leaders have elevated concerns around China’s trade practices, including currency manipulation, intellectual property theft, and allegations that China is directing or enabling fentanyl to flood into the U.S.

Trade and public health are increasingly linked, as COVID revealed the vulnerability of medical supply chains when U.S. overreliance on China led to delays and shortages of masks and personal protective equipment. Another issue that’s getting more attention from lawmakers and parents is the prevalence of Chinese-made, counterfeit electronic cigarettes or “vapes” throughout the U.S. Politicians from Senator Ashley Moody (R-FL) to President Trump himself have raised the alarm.

At the same time, American manufacturers have bemoaned the slow and stringent regulatory process they have faced at the FDA, which they say has enabled China to flood the market with cheap, sketchy alternatives. With a new FDA administrator set to take the helm, key questions remain. How did we end up in this situation, and what are the lessons not just for public health, but for other areas where the U.S. is looking to tighten up its trade policy. Is it possible for the U.S. to maintain the ideal of a relatively free market without adversaries exploiting that freedom?

Evan is joined by Joel Thayer, President of the Digital Progress Institute. You can read his op-ed on illicit vapes, the Bloomberg report we discuss in the episode, as well as Aiden Buzzetti’s op-ed in CommonPlace.

  continue reading

115 episodes

Artwork
iconShare
 
Manage episode 472619620 series 3530279
Content provided by Max Bodach and Foundation for American Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Max Bodach and Foundation for American Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

It’s an understatement that U.S.-China relations have been tense in recent years. Policymakers and industry leaders have elevated concerns around China’s trade practices, including currency manipulation, intellectual property theft, and allegations that China is directing or enabling fentanyl to flood into the U.S.

Trade and public health are increasingly linked, as COVID revealed the vulnerability of medical supply chains when U.S. overreliance on China led to delays and shortages of masks and personal protective equipment. Another issue that’s getting more attention from lawmakers and parents is the prevalence of Chinese-made, counterfeit electronic cigarettes or “vapes” throughout the U.S. Politicians from Senator Ashley Moody (R-FL) to President Trump himself have raised the alarm.

At the same time, American manufacturers have bemoaned the slow and stringent regulatory process they have faced at the FDA, which they say has enabled China to flood the market with cheap, sketchy alternatives. With a new FDA administrator set to take the helm, key questions remain. How did we end up in this situation, and what are the lessons not just for public health, but for other areas where the U.S. is looking to tighten up its trade policy. Is it possible for the U.S. to maintain the ideal of a relatively free market without adversaries exploiting that freedom?

Evan is joined by Joel Thayer, President of the Digital Progress Institute. You can read his op-ed on illicit vapes, the Bloomberg report we discuss in the episode, as well as Aiden Buzzetti’s op-ed in CommonPlace.

  continue reading

115 episodes

所有剧集

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Listen to this show while you explore
Play